Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The ‘Bevacizumab in Trabeculectomy Study’

Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The ‘Bevacizumab in Trabeculectomy Study’ | ReachRx